Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.13% is 97% below its 5-year average of 4.11%, near the low end of its 5-year range (0.00%–36.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 75.50% below its 12-month average of 0.54%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 0.13%.
DEBT TO ASSETS RATIO
0.13%
DEBT TO ASSETS RATIO AVG TTM
0.54%
DEBT TO ASSETS RATIO AVG 3Y
6.43%
DEBT TO ASSETS RATIO AVG 5Y
4.11%
DEBT TO ASSETS RATIO AVG 10Y
5.14%
DEBT TO ASSETS RATIO AVG 15Y
5.99%
DEBT TO ASSETS RATIO AVG 20Y
5.87%
CURRENT VS TTM AVG
-75.50%
CURRENT VS 3Y AVG
-97.95%
CURRENT VS 5Y AVG
-96.80%
CURRENT VS 10Y AVG
-97.44%
CURRENT VS 15Y AVG
-97.80%
CURRENT VS 20Y AVG
-97.76%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+31.54%
vs the sector median at left
Incannex Healthcare Limited
Market Cap
$38.82M
Debt to Assets Ratio
0.13%
TTM Avg
0.54%
3Y Avg
6.43%
5Y Avg
4.11%
Market Cap
$38.52M
Debt to Assets Ratio
0.58%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.92M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.61M
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.17M
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $38.82M | 0.13% | 0.54% | 6.43% | 4.11% |
| Nephros, Inc. (NEPH)vs › | $38.64M | 0.06% | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | 0.58% | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | 0.22% | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $36.92M | 0.00% | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | 0.45% | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.32M | 0.14% | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $36.17M | 0.41% | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $41.56M | 0.64% | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.81M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.1%
Debt/Equity
0.00
Current Ratio
48.81
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.13% |
| 2025-12-31 | 0.22% |
| 2025-06-30 | 1.26% |
| 2024-12-31 | 36.89% |
| 2024-06-30 | 2.19% |
| 2023-12-31 | 2.10% |
| 2023-06-30 | 2.19% |
| 2022-12-31 | 0.24% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 12.55% |
| 2018-12-31 | 11.26% |
| 2018-06-30 | 28.25% |
| 2017-12-31 | 17.73% |
| 2017-06-30 | 39.74% |
| 2016-12-31 | 14.47% |
| 2016-06-30 | 202.61% |
| 2015-12-31 | 68.04% |
| 2015-06-30 | 15.94% |
| 2014-12-31 | 11.58% |
| 2014-06-30 | 11.94% |
| 2013-12-31 | 4.77% |
| 2013-06-30 | 7.59% |
| 2012-12-31 | 5.28% |
| 2012-06-30 | 3.99% |
| 2011-12-31 | 3.90% |
| 2011-06-30 | 4.15% |
| 2010-12-31 | 10.18% |
| 2010-06-30 | 11.81% |
| 2009-12-31 | 42.13% |
| 2009-06-30 | 43.23% |
| 2008-12-31 | 112.23% |
| 2008-06-30 | 1.00% |
| 2007-12-31 | 1.89% |
| 2007-06-30 | 1.18% |
